Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures
Single Center, Randomized Control Trial of Cryoablation During Surgical Stabilization of Rib Fractures
1 other identifier
interventional
80
1 country
1
Brief Summary
To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of Surgical Stabilization of Rib Fractures (SSRF) without cryoablation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2022
CompletedFirst Posted
Study publicly available on registry
June 13, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
March 16, 2026
March 1, 2026
3.8 years
June 6, 2022
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Morphine Milligram Equivalents Use following Intervention
To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.
Baseline
Morphine Milligram Equivalents Use following Intervention
To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.
Day 1
Morphine Milligram Equivalents Use following Intervention
To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.
Day 30
Morphine Milligram Equivalents Use following Intervention
To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.
Day 90
Secondary Outcomes (7)
Number of days in Hospital Stay
Days during admission
Number of days in ICU Stay
Day 90
Amount of Chest tube drainage
Day 90
Quality of Life Scores
Month 1 and Month 3
Number of Mortalities in hospital
Day 90
- +2 more secondary outcomes
Study Arms (2)
Surgical Stabilization of Rib Fractures plus Multimodal Pain Therapy plus CRYOABLATION
EXPERIMENTALAdding Cryoablation of levels 3-8, in addition to patients that undergo SSRF for multiple rib fractures.
Surgical Stabilization of Rib Fractures plus Multimodal Pain Therapy
ACTIVE COMPARATORStandard surgical treatment of patients with multiple rib fractures plus Multimodal Pain Therapy
Interventions
Using Atricure device, cryoice, intercostal nerves 3-8 will be ablated in the experimental arm. This is in addition to mechanical fixation of rib fractures and multimodal systemic therapy.
Standard surgical treatment of patients with multiple rib fractures
Eligibility Criteria
You may qualify if:
- The patient is admitted to the trauma service.
- The patient has multiple displaced rib fractures (≥2 ribs), offered fixation, and consents to SSRF
- The patient is not being treated for chronic pain
- The patient is \>18 years of age.
- Surgery anticipated \<120 hours from injury
You may not qualify if:
- Age \< 18 years or ≥ 80 years
- Flail chest: either radiographic or clinical. Radiographic flail chest is defined on CT chest as ≥ 2 ribs each fractured in ≥ 2 places. Clinical flail is defined as visualization of a segment of chest wall with paradoxical motion on physical exam.
- Moderate or severe traumatic brain injury (Intra-cranial hemorrhage visualized on CT head with GCS at the time of consideration for enrollment \< 12)
- Prior or expected emergency exploratory laparotomy during this admission
- Prior or expected emergency thoracotomy during this admission
- Prior or expected emergency craniotomy during this admission
- Spinal cord injury
- Pelvic fracture that has required, or is expected to require, operative intervention during this admission
- The patient was unable to accomplish activities of daily living independently prior to injury (e.g., dressing, bathing, preparing meals)
- The patient is incarcerated
- The patient is known to be pregnant
- Unable to perform Video Assisted Thoracoscopy (VATS) at time of SSRF due to lung isolation or previous pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bradely W. Thomas, MD
Wake Forest University Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The study will blind patients to whether or not they underwent cryoneurolysis
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2022
First Posted
June 13, 2022
Study Start
August 1, 2022
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share